Vital Farms (NASDAQ:VITL) Price Target Increased to $30.00 by Analysts at Stifel Nicolaus

Vital Farms (NASDAQ:VITL) had its target price lifted by Stifel Nicolaus from $22.00 to $30.00 in a report released on Friday morning, Benzinga reports. They currently have a buy rating on the stock.

Several other brokerages also recently weighed in on VITL. William Blair assumed coverage on Vital Farms in a report on Wednesday, April 10th. They issued an outperform rating for the company. TheStreet raised shares of Vital Farms from a c rating to a b- rating in a research report on Monday, March 18th. Finally, Lake Street Capital boosted their target price on shares of Vital Farms from $26.00 to $32.00 and gave the stock a buy rating in a research report on Wednesday. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Moderate Buy and an average target price of $23.00.

Vital Farms Trading Up 2.1 %

NASDAQ:VITL opened at $27.00 on Friday. The firm has a 50 day moving average of $22.18 and a 200 day moving average of $16.64. The company has a quick ratio of 2.49, a current ratio of 3.00 and a debt-to-equity ratio of 0.05. Vital Farms has a 52 week low of $10.00 and a 52 week high of $27.37. The stock has a market capitalization of $1.13 billion, a price-to-earnings ratio of 46.55 and a beta of 0.89.

Vital Farms (NASDAQ:VITL) last issued its quarterly earnings data on Thursday, March 7th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.14 by $0.03. The firm had revenue of $135.81 million during the quarter, compared to analyst estimates of $131.10 million. Vital Farms had a return on equity of 14.22% and a net margin of 5.42%. During the same quarter in the prior year, the business posted $0.04 EPS. As a group, sell-side analysts anticipate that Vital Farms will post 0.77 earnings per share for the current fiscal year.

Insider Transactions at Vital Farms

In related news, CEO Russell Diez-Canseco sold 27,528 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $15.49, for a total value of $426,408.72. Following the transaction, the chief executive officer now owns 223,568 shares in the company, valued at approximately $3,463,068.32. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, CEO Russell Diez-Canseco sold 27,528 shares of the firm’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $15.49, for a total transaction of $426,408.72. Following the completion of the transaction, the chief executive officer now owns 223,568 shares of the company’s stock, valued at $3,463,068.32. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Jason Dale sold 14,006 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $16.03, for a total transaction of $224,516.18. Following the completion of the transaction, the chief operating officer now owns 48,455 shares of the company’s stock, valued at $776,733.65. The disclosure for this sale can be found here. Insiders sold a total of 260,125 shares of company stock worth $5,580,996 over the last three months. 30.20% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Vital Farms

A number of institutional investors have recently modified their holdings of VITL. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Vital Farms by 52.8% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,196 shares of the company’s stock worth $95,000 after purchasing an additional 2,833 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Vital Farms by 211.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,175 shares of the company’s stock worth $97,000 after buying an additional 4,192 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Vital Farms during the 3rd quarter valued at approximately $119,000. DekaBank Deutsche Girozentrale acquired a new stake in Vital Farms in the 4th quarter valued at $127,000. Finally, New York State Common Retirement Fund increased its holdings in Vital Farms by 49.0% in the 4th quarter. New York State Common Retirement Fund now owns 10,169 shares of the company’s stock worth $160,000 after acquiring an additional 3,346 shares in the last quarter. 98.59% of the stock is currently owned by institutional investors and hedge funds.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.